Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

G-Plans vs Rixa Health

G-Plans
Graded #462

Lower grade

vs+6.700000000000003
Rixa Health
Graded #320

Higher grade

The verdict

Rixa Health takes it — 60.5/100 to 53.8/100.

Rixa Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rixa Health is a direct-to-consumer functional-medicine telehealth practice prescribing compounded and oral semaglutide and tirzepatide (plus other peptides) for weight loss via partner US pharmacies.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationRixa Health +11
40
51
Clinical oversightRixa Health +13
72
85
Labs & monitoringRixa Health +10
53
63
FulfillmentRixa Health +13
65
78
Contract termsG-Plans +14
55
41
G-Plans · left barRixa Health · right bar

The numbers

MetricG-PlansRixa Health
WeighScore53.8/10060.5/100
GradeCC
Scorecard rank#462#320
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
G-Plans

Graded #462 · C

Strengths

  • Both semaglutide and tirzepatide available

Where it loses points

  • Pricing not publicly disclosed
Rixa Health

Graded #320 · C

Strengths

  • Functional-medicine, root-cause clinical approach
  • Compounded and oral semaglutide plus tirzepatide offered
  • Board-certified DO and FNP providers with years of experience
  • Medication bundled with visits into a single price
  • No charge until after approval

Where it loses points

  • No public monthly pricing; quoted only during consultation
  • Relies on compounded GLP-1, which is not FDA-approved as a finished drug
  • A handful of states still listed as coming soon
  • Branded GLP-1 medications are not the primary offering
  • Requires ongoing monthly follow-up commitment

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard